SCHEMBL17148648

SCHEMBL17148648

Cc1cc(C(=O)NC2CCC(C(C)(C)C)C2)cc(C(=O)NC2CCC(C(C)(C)C)C2)c1

nearest known ligand 0.47

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
POLB P06746 1/20 0.47
TAS1R3 Q7RTX0 3/20 0.44
TAS1R1 Q7RTX1 3/20 0.44
TAS1R2 Q8TE23 3/20 0.44
SMYD3 Q9H7B4 3/20 0.44
NPC1 O15118 2/20 0.43
RAB9A P51151 2/20 0.43
HPGDS O60760 5/20 0.41
CYP1A2 P05177 1/20 0.41
HPGD P15428 1/20 0.41
CYP2C19 P33261 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
PTGS1 P23219 1/20 0.40
PTGS2 P35354 1/20 0.40
EPHX1 P07099 1/20 0.40
GRM5 P41594 1/20 0.39
TACR1 P25103 1/20 0.39
MEN1 O00255 1/20 0.38
KMT2A Q03164 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17148647 0.86 EPHX1 (0.51) POLBTAS1R3TAS1R1TAS1R2SMYD3
SCHEMBL2457237 0.85 GRM5 (0.48) NPC1RAB9ACYP1A2HPGDCYP2C19
SCHEMBL2455994 0.84 EPHX1 (0.54) TAS1R3TAS1R1TAS1R2SMYD3NPC1
SCHEMBL17149225 0.82 POLB (0.44) POLBTAS1R3TAS1R1TAS1R2SMYD3
SCHEMBL17148691 0.79 SMYD3 (0.40) POLBTAS1R3TAS1R1TAS1R2SMYD3
SCHEMBL18902161 0.76 NPC1 (0.53) POLBTAS1R3TAS1R1TAS1R2SMYD3
SCHEMBL16622848 0.76 TAS1R3 (0.57) POLBTAS1R3TAS1R1TAS1R2SMYD3
SCHEMBL16622850 0.76 RAB9A (0.69) POLBTAS1R3TAS1R1TAS1R2SMYD3
SCHEMBL17148635 0.76 SMYD3 (0.61) SMYD3NPC1RAB9AHPGDSHPGD
SCHEMBL9979043 0.76 TAS1R3 (0.40) TAS1R3TAS1R1TAS1R2HPGDSEPHX1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20150287920-A1 ORGANIC ELECTROLUMINESCENT DEVICE HODOGAYA CHEMICAL CO., LTD. (JP) 2015-10-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150287920-A1 ORGANIC ELECTROLUMINESCENT DEVICE CDH1, STRA6, SLC39A7 POLB 2855/4885TAS1R3 3567/4885TAS1R1 2190/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.